Acute Lymphoblastic Leukemia in Children
Author:
Publisher
Deutscher Arzte-Verlag GmbH
Subject
General Medicine
Reference29 articles.
1. Riehm H, Gadner H, Henze G, et al.: Results and significance of six randomized trials in four consecutive ALL BFM trials. Haematol Blood Transf 1990; 33: 439–50.
2. Conter V, Aricò M, Basso G, et al.: Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 2010; 24: 255–64.
3. Pui CH, Evans WE: Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166–78.
4. Moghrabi A, Levy DE, Asselin B, et al.: Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95–01 for children with acute lymphoblastic leukemia. Blood 2007; 109: 896–904.
5. Aricò M, Valsecchi MG, Rizzari C, et al.: Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol 2008; 26: 283–9.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of the Multidrug resistance 1 gene polymorphisms on the outcome of therapy in childhood acute leukemia in Duhok province/Iraq;Iraqi Journal of Hematology;2023
2. Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease;Oncohematology;2020-10-16
3. Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases;Frontiers in Oncology;2020-06-30
4. High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia;Frontiers in Pharmacology;2020-06-17
5. Effect of dose and schedule of L-asparaginase administration on early minimal residual disease in acute lymphoblastic leukemia;Indian Journal of Medical and Paediatric Oncology;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3